Catherine Riva of Re-Check was selected by the organizers of the Conference to present the results of her investigation on the “mammo-business”, an extensive system of business models and careers building grown in Switzerland around mammography screening. Her long-form investigative piece was honored in 2014 with a Media Award of the Swiss Academies of Medical Sciences. [...]
The crossroads between Evidence Based Medicine and investigation: Re-Check training day in Fribourg (Switzerland) With Catherine Riva and Serena Tinari (Re-Check), Thomas Angeli (Lobbywatch), Manolo Luppichini (reporter) and Prof. Thierry Buclin (Division de toxicologie et de pharmacologie clinique, CHUV, Lausanne).
By Abby Lippman, Professor Emerita, Department of Epidemiology, Biostatistics and Occupational Health, McGill University; Research Associate, Simone de Beauvoir Institute, Concordia University Published on bioethiqueonline.ca, 14 Jun 2017 Sometimes, perhaps too often, a “bad idea this way comes” and one of the latest is not just “bad” but rather horrifying to me — and perhaps to [...]
HPV testing is now recommended in several countries (In Holland and USA, for example) to replace the Pap test (cytology) for primary screening of cervical cancer. Roche is one of the big players in this field with its cobas® HPV test. The marketing of the new version was announced on March 28, 2017. The market of [...]
Re-Check est en ligne! We are online! Suivez-nous sur les réseaux sociaux! Join us on Twitter and Facebook!
